Italfarmaco: Accelerating Rare Disease Launch with Vault CRM
"The successful implementation of Vault CRM was a cornerstone of our launch, driven by the deep commitment, seamless collaboration, and mutual support shared between Veeva and Italfarmaco."
Simona Gay, 2025 Veeva Hero, shares the challenge of launching a new rare disease division and a groundbreaking product across Europe and how it required them to establish a strong operational foundation quickly. The company selected Veeva as a strategic partner to deploy commercial and medical operations on a single, unified platform.
Launching a new division in record time
Entering a complex, highly specialized market required speed and accuracy. The primary challenge for Italfarmaco was implementing core systems across multiple European countries, balancing standardization for efficiency with the need for country-specific personalization to meet local legislative requirements.
Unified commercial and medical operations
Italfarmaco adopted Veeva Vault CRM to enable rapid, scalable launches across Europe. By unifying the commercial and medical teams on a single platform, the company achieved a complete, 360-degree view of the customer journey. This unified data model allows for real-time engagement measurement—including digital interactions like email opens and website visits—all in one system.
Foundation for growth and future innovation
The unified platform has laid the groundwork for future growth, allowing Italfarmaco to drive new strategies and make decisions based on high-quality data. Looking ahead, the company anticipates significant benefits from AI embedded in the system and achieving a perfectly integrated, measurable omnichannel strategy.
Achieve launch excellence with confidence and speed with Vault CRM.
